Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00479726 · ClinicalTrials.gov registry record · Phase 4
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 8,000
- Enrollment target
NCT00479726: Completed Phase 4 study, sponsored by Eli Lilly and Company.
NCT00479726 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 8,000 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (1444% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00479726, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8,000 participants
- Enrollment target
Study Summary
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
Interventions
- DRUG duloxetine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
What the finished NCT00479726 record still lists
NCT00479726 is an interventional study that assigns participants to a tested intervention. Its 8,000 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (1444% higher).
The record links to 0 conditions, and to 1 intervention - of which duloxetine hydrochloride is the first listed.
NCT00479726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00479726 about?
NCT00479726 is a clinical study titled "Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)". To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
What is the current status of trial NCT00479726?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8,000 participants. The study started on 2004-08. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00479726?
The interventions under investigation include: duloxetine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00479726?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00479726's enrollment target sits among peer trials
8,000 10th of 2000 higher than 1,990 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia